Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm

See also
Status	Clinical Trial	Phase
Completed	`NCT05160142` - Diabetes Inspired Culinary Education	Early Phase 1
Withdrawn	`NCT05035368` - Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes	Phase 2
Completed	`NCT01928329` - A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes	Phase 2
Completed	`NCT02127762` - The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy	N/A
Completed	`NCT00999375` - Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)	Phase 2
Completed	`NCT04279613` - A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041	Phase 1
Not yet recruiting	`NCT02117518` - Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients	N/A
Withdrawn	`NCT01477476` - Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes	Phase 2
Terminated	`NCT01308437` - Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics	Phase 3
Terminated	`NCT01652911` - A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation	Phase 1/Phase 2
Completed	`NCT06242548` - How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude	N/A
Completed	`NCT00351650` - Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan	N/A
Withdrawn	`NCT00361608` - Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device	N/A
Terminated	`NCT03653533` - Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump	N/A
Completed	`NCT00340639` - Management of Type 1 Diabetes Among Adolescents	N/A
Completed	`NCT02634216` - Effects of Capros in Patients With Type-1 Diabetes	N/A
Completed	`NCT02002130` - The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes	Phase 1
Withdrawn	`NCT01623388` - Epigenetic Modifications of Diabetes Mellitus Type I	N/A
Completed	`NCT02612493` - Obesity and Metabolic Surgery in Patients With Type I Diabetes	N/A
Completed	`NCT01843114` - Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects	N/A

NCT number	NCT05151770
Study type	Observational
Source	M-DT1
Contact
Status	Completed
Phase
Start date	December 30, 2021
Completion date	December 30, 2022

Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm — EGHYA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms